Cost-Effectiveness Analysis of Atezolizumab Compared To The Standard of Care For The Treatment of Adult Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) After Prior Chemotherapy in Greece
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.233
https://www.valueinhealthjournal.com/article/S1098-3015(17)30567-3/fulltext
Title :
Cost-Effectiveness Analysis of Atezolizumab Compared To The Standard of Care For The Treatment of Adult Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) After Prior Chemotherapy in Greece
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)30567-3&doi=10.1016/j.jval.2017.08.233
First page :
A439
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
216